查看購物車
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
2003972

不孕症檢測設備市場：依產品類型、技術、最終用戶和銷售管道分類－2026-2032年全球市場預測

Fertility Testing Devices Market by Product Type, Technology, End User, Sales Channel - Global Forecast 2026-2032
出版日期: | 出版商: 360iResearch | 英文 185 Pages | 商品交期: 最快1-2個工作天內

價格

※ 本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

預計到 2025 年，不孕症檢測設備市場價值將達到 7.0228 億美元，到 2026 年將成長至 7.4083 億美元，到 2032 年將達到 10.6628 億美元，複合年成長率為 6.14%。

主要市場統計數據
基準年 2025 7.0228億美元
預計年份：2026年 7.4083億美元
預測年份 2032 1,066,280,000 美元
複合年成長率 (%) 6.14%

全面概述了技術、監管和消費者因素如何融合，從而重塑不孕症檢測設備及其分銷管道。

隨著技術日趨成熟、消費者行為不斷演變以及臨床實踐的進步，生育力檢測設備市場正處於關鍵的轉折點。曾經僅限於實驗室的新型診斷技術如今已觸手可及，消費者可以輕鬆獲得這些技術，從而在家庭診斷和臨床護理之間建立起新的聯繫。本文旨在為希望了解設備外形、使用者體驗和資料生態系統如何說明生殖醫學決策的利害關係人相關人員。

穿戴式科技、演算法分析、消費者期望和不斷發展的供應鏈如何共同作用，重新定義不孕症檢測設備的未來。

不孕症檢測設備領域正經歷一場變革，這場變革由多個相互關聯的因素共同推動，遠非簡單的產品改進所能比擬。穿戴式技術正從單一參數監測轉向整合生理訊號的多感測器平台，從而實現連續評估而非間歇性測量。同時，數位演算法和雲端分析技術的進步正將原始感測器數據轉化為預測性洞察，為消費者和臨床醫生創造新的價值。

對關稅變化和貿易政策轉變如何重塑整個生育力檢測設備供應鏈的採購、生產決策和業務永續營運進行全面評估。

近期貿易政策和關稅措施的變化給生育檢測設備的製造商和經銷商帶來了新的挑戰。零件和成品診斷設備關稅的提高增加了跨境採購成本，迫使企業重新評估關鍵零件的製造、組裝和採購流程。這種轉變正在影響其整個商業化策略的單位經濟效益、前置作業時間和緊急時應對計畫。

細分市場主導的策略明確：確定產品類型、最終用戶、銷售管道和技術方法如何決定開發和商業化優先事項。

精準的市場區隔觀點能夠明確產品創新和商業化工作的重點方向。根據產品類型，不孕症監測儀、排卵檢測套組和懷孕檢測套組的研發和推廣路徑各不相同。不孕症監測儀可細分為手持式和腕式設備，前者著重於連續測量、感測器整合和使用者舒適度。排卵檢測套組有數位式和傳統式兩種，其競爭重點在於結果的可讀性和分析準確性；而妊娠檢測套組同樣有數位式和傳統式兩種，則需要在靈敏度和易用性之間取得平衡。

法律規範、消費者行為和分銷生態系統在重點地區對產品策略和市場進入方式的影響。

區域趨勢對監管策略、分銷模式和產品設計要求有顯著影響。在美洲，消費者對家庭醫療保健解決方案的強勁需求，加上成熟的遠端醫療基礎設施，使得數位化設備和訂閱服務擁有了競爭優勢。法律規範力求在消費者保護和創新之間取得平衡，而關於保險報銷的討論也日益關注如何將檢驗的家庭測量數據整合到更廣泛的醫療服務路徑中。因此，在美洲營運的公司通常會優先考慮隱私合規、資料互通性以及與臨床網路的合作。

深入了解不孕症檢測設備市場中市場領導和快速追隨者之間的競爭行為、夥伴關係模式和能力配置差異。

生育檢測設備領域的競爭動態是由多種因素共同塑造的：既有不斷拓展數位化能力的成熟企業，也有利用創新外形規格的敏捷新興企業，還有來自穿戴式裝置和數位健康領域的跨產業新秀。那些擅長將臨床級感測技術與無縫用戶體驗結合的公司，往往能與醫療服務提供者和遠端醫療平台建立更緊密的夥伴關係。設備製造商與數位服務供應商之間的合作，正在催生整合硬體、軟體和醫療協調服務的捆綁式解決方案。

針對製造商、經銷商和醫療保健系統，制定具體且優先的策略舉措，以避免生育力檢測領域的風險並抓住機會。

產業領導企業應優先採取一系列策略行動，以建立長期競爭優勢並保持敏捷性。首先，使產品藍圖與監管證據要求和隱私標準保持一致，可以縮短臨床認可時間並最大限度地減少返工。其次，投資模組化硬體平台和軟體升級能力可以降低迭代功能開發的成本，並且能夠快速回應使用者回饋和監管變化。第三，供應商多元化和探索區域製造方案可以降低關稅風險並縮短前置作業時間。

採用詳細的混合方法研究途徑，結合專家訪談、證據整合和技術檢驗，可以得出令人信服且可操作的見解。

本研究採用混合方法，結合一手質性訪談、結構化二手證據整合和技術檢驗，以得出可靠且可操作的結論。關鍵輸入包括對臨床醫生、器材工程師、監管專家和通路合作夥伴的訪談，以了解從業人員的觀點、技術限制和實際商業化挑戰。透過與這些相關人員的對話，對證據進行三角驗證，以識別不同領域和地區在推廣應用方面面臨的實際障礙。

對策略挑戰進行簡潔整合，強調將技術卓越、證據生成和營運韌性相結合，以實現永續的成功。

不孕症檢測設備的市場格局瞬息萬變，既蘊藏著巨大的商機，也帶來了嚴峻的營運挑戰。技術進步為消費者和臨床醫生創造了新的價值，但要充分發揮這些潛力，需要精心協調產品設計、臨床檢驗、監管策略和供應鏈韌性。積極主動解決資料完整性、隱私和互通性的機構，將更有能力把設備功能轉化為整合的診療路徑。

目錄

第1章：序言

第2章：調查方法

  • 調查設計
  • 研究框架
  • 市場規模預測
  • 數據三角測量
  • 調查結果
  • 調查的前提
  • 研究限制

第3章執行摘要

  • 首席體驗長觀點
  • 市場規模和成長趨勢
  • 2025年市佔率分析
  • FPNV定位矩陣，2025
  • 新的商機
  • 下一代經營模式
  • 產業藍圖

第4章 市場概覽

  • 產業生態系與價值鏈分析
  • 波特五力分析
  • PESTEL 分析
  • 市場展望
  • 上市策略

第5章 市場洞察

  • 消費者洞察與終端用戶觀點
  • 消費者體驗基準
  • 機會映射
  • 分銷通路分析
  • 價格趨勢分析
  • 監理合規和標準框架
  • ESG與永續性分析
  • 中斷和風險情景
  • 投資報酬率和成本效益分析

第6章：美國關稅的累積影響，2025年

第7章：人工智慧的累積影響，2025年

第8章：不孕症檢測設備市場：依產品類型分類

  • 排卵監測
    • 攜帶式顯示器
    • 清單類型監視器
  • 排卵檢測套組
    • 數位的
    • 傳統的
  • 檢測套組
    • 數位的
    • 傳統的

第9章：不孕症檢測設備市場：依技術分類

  • 數位的
  • 傳統的

第10章：不孕症檢測設備市場：依最終用戶分類

  • 臨床應用
  • 家用

第11章：不孕症偵測設備市場：依銷售管道分類

  • 線上
  • 離線

第12章：不孕症檢測設備市場：依地區分類

  • 北美洲和南美洲
    • 北美洲
    • 拉丁美洲
  • 歐洲、中東和非洲
    • 歐洲
    • 中東
    • 非洲
  • 亞太地區

第13章：不孕症檢測設備市場：依類別分類

  • ASEAN
  • GCC
  • EU
  • BRICS
  • G7
  • NATO

第14章 不孕症檢測設備市場：依國家分類

  • 美國
  • 加拿大
  • 墨西哥
  • 巴西
  • 英國
  • 德國
  • 法國
  • 俄羅斯
  • 義大利
  • 西班牙
  • 中國
  • 印度
  • 日本
  • 澳洲
  • 韓國

第15章：美國不孕症檢測設備市場

第16章：中國不孕症檢測設備市場

第17章 競爭格局

  • 市場集中度分析，2025年
    • 濃度比（CR）
    • 赫芬達爾-赫希曼指數 (HHI)
  • 近期趨勢及影響分析，2025 年
  • 2025年產品系列分析
  • 基準分析，2025 年
  • Abbott Laboratories Inc.
  • Advait Labs Private Limited.
  • Babystart Inc.
  • bioMerieux SA
  • Church & Dwight Co., Inc.
  • Clearblue
  • Easy Healthcare Corporation
  • First Response
  • Geratherm Medical AG
  • Hi-Precision Company
  • Medical Electronic Systems LLC
  • NFI Consumer Healthcare
  • Piramal Enterprises Ltd
  • Precision Biosensor Inc.
  • QuidelOrtho Corporation
  • Rite Aid Corporation
  • Rohto Pharmaceutical Co., Ltd.
  • Swiss Precision Diagnostics GmbH
  • Tempdrop Ltd
  • UE Lifecycles Inc.
Product Code: MRR-2D6687430273

The Fertility Testing Devices Market was valued at USD 702.28 million in 2025 and is projected to grow to USD 740.83 million in 2026, with a CAGR of 6.14%, reaching USD 1,066.28 million by 2032.

KEY MARKET STATISTICS
Base Year [2025] USD 702.28 million
Estimated Year [2026] USD 740.83 million
Forecast Year [2032] USD 1,066.28 million
CAGR (%) 6.14%

A comprehensive orientation to the converging technological, regulatory, and consumer forces reshaping fertility testing devices and adoption pathways

The fertility testing devices landscape stands at a pivotal juncture as technological maturation, shifting consumer behavior, and evolving clinical practices converge. Emerging diagnostic capabilities that were once confined to research laboratories are now accessible in consumer-friendly formats, creating new intersections between at-home diagnostics and clinical care. This introduction frames the context for stakeholders seeking to understand how device form factors, user experience, and data ecosystems are reshaping reproductive health decisions.

Adoption is being driven by a combination of device miniaturization, improvements in sensor fidelity, and software-driven interpretation that reduce the cognitive burden on end users and clinicians alike. At the same time, regulators and payers are adapting to evaluate the clinical validity and real-world utility of digitally enabled diagnostics, which influences product design and commercialization pathways. As a result, manufacturers must reconcile engineering choices with regulatory strategy and reimbursement positioning to navigate time to adoption effectively.

This section sets the stage for an integrated analysis of technological disruptions, policy forces, and behavioral trends that together determine competitive dynamics. It emphasizes the need for cross-functional strategies that align research and development, clinical evidence generation, and channel partnerships. Ultimately, the introduction underscores both the opportunity and complexity inherent in delivering reliable, accessible fertility testing solutions that meet diverse clinical and consumer needs.

How wearables, algorithmic analytics, consumer expectations, and supply chain evolution are jointly redefining the future of fertility testing devices

The landscape for fertility testing devices is being transformed by several interrelated shifts that extend beyond incremental product improvements. Wearable technologies are moving from single-parameter monitoring to multi-sensor platforms that integrate physiological signals, enabling continuous assessment rather than episodic measurement. Concurrently, advances in digital algorithms and cloud analytics are converting raw sensor data into predictive insights, creating new forms of value for both consumers and clinicians.

Consumer expectations are shifting toward convenience, privacy, and actionable guidance. This behavioral change has encouraged manufacturers to prioritize user experience, unassisted interpretation, and seamless integration with telehealth services. Meanwhile, clinical stakeholders are increasingly open to accepting validated home-based measurements as complementary evidence, provided that data quality and interoperability standards are met. This convergence reduces friction between home use and clinical decision-making and opens pathways for hybrid care models.

Supply chain innovations and modular manufacturing approaches are enabling faster iteration cycles and more localized production for high-demand components. In parallel, partnerships between device makers and digital health platforms are expanding the scope of service offerings to include subscription-based services, remote monitoring programs, and longitudinal analytics. Each of these shifts amplifies the need for robust privacy protections, transparent algorithmic validation, and clear regulatory strategies to maintain trust and ensure scalable adoption.

Comprehensive assessment of how tariff shifts and trade policy changes are reshaping sourcing, production decisions, and commercial resilience across fertility device supply chains

Trade policy changes and tariff measures implemented in recent years have created a new calculus for manufacturers and distributors of fertility testing devices. Tariffs on components and finished diagnostic units have increased the cost of cross-border sourcing, prompting organizations to reassess where to manufacture, assemble, and procure critical parts. This shift has implications for unit economics, lead times, and contingency planning that ripple across commercialization strategies.

In response, many firms are exploring diversification of supplier portfolios and increased regionalization of production to reduce exposure to single-market shocks. Nearshoring and dual-sourcing strategies are being evaluated not only to manage tariff risk but also to shorten supply chains and enhance responsiveness to demand fluctuations. At the same time, some manufacturers are redesigning products to use alternative components that are less exposed to tariffed categories, thereby preserving margins without compromising performance.

Tariff-driven cost pressures also influence channel strategies. Some distributors and retailers may absorb part of the increased input costs to preserve retail price points, while others will negotiate revised commercial terms with suppliers. Additionally, increased scrutiny on customs classification and compliance has raised administrative overhead for exporters and importers, reinforcing the need for stronger legal and trade advisory capabilities within commercial teams. Looking forward, scenario planning that accounts for sustained tariff volatility will be essential to preserve resilience and protect commercialization timelines.

Segment-driven strategic clarity revealing how product types, end users, sales channels, and technological approaches determine development and commercialization priorities

A nuanced segmentation lens clarifies where product innovation and commercialization effort should be concentrated. Based on product type, fertility monitors, ovulation test kits, and pregnancy test kits each follow distinct development and adoption dynamics. Fertility monitors, which are further divided into handheld monitors and wrist monitors, emphasize continuous measurement, sensor integration, and user comfort. Ovulation test kits, available in digital and traditional formats, compete on ease of interpretation and analytical accuracy, while pregnancy test kits, which also come in digital and traditional versions, must balance sensitivity with usability.

End users shape design priorities and validation requirements. Clinical use demands higher evidentiary standards, integration into electronic health records, and robust data provenance, while home use prioritizes simplicity, privacy, and clear guidance for users who may not have clinical support. Sales channel considerations also influence product configuration and packaging, as online channels favor direct-to-consumer engagement, subscription models, and digital onboarding, whereas retail channels require shelf-ready designs, clear labeling, and point-of-sale differentiation. Technology choices, split between digital and traditional approaches, determine the pace of feature upgrades and the potential for value-added software services.

Understanding the interaction among product type, end user, sales channel, and technology axis allows organizations to prioritize R&D investments, evidence-generation plans, and channel partnerships. For example, a wrist monitor targeting home use and digital sales demands a different clinical validation roadmap and user experience design than a traditional ovulation strip sold through retail. Segment-specific strategies enable more efficient resource allocation and clearer go-to-market pathways.

How regional regulatory frameworks, consumer behaviors, and distribution ecosystems across major geographies influence product strategy and market entry approaches

Regional dynamics materially influence regulatory strategy, distribution models, and product design requirements. In the Americas, a combination of strong consumer demand for at-home health solutions and an established telehealth infrastructure favors digitally enabled devices and subscription services. Regulatory pathways balance consumer protection with innovation, and reimbursement conversations increasingly focus on integrating validated home measurements into broader care pathways. As a result, companies operating in the Americas often prioritize privacy compliance, data interoperability, and partnerships with clinical networks.

Across Europe, Middle East & Africa, regulatory heterogeneity and diverse healthcare delivery systems necessitate tailored market entry strategies. In some European jurisdictions, rigorous clinical validation and alignment with national health technology assessment frameworks are critical, while in parts of the Middle East and Africa, distribution constraints and different payer dynamics require alternative commercial models, such as public-private partnerships or franchise distribution arrangements. Localization of language, cultural considerations around reproductive health, and logistics capabilities are important determinants of success in these regions.

In the Asia-Pacific region, high rates of mobile adoption, rapid digital health innovation, and large consumer populations create fertile ground for scalable direct-to-consumer offerings and integrated telehealth services. However, regulatory regimes and reimbursement standards vary widely, and price sensitivity in many markets favors cost-effective form factors and high-volume manufacturing approaches. Strategic entrants often adopt phased rollouts, leveraging pilot programs and local partnerships to adapt product features and messaging to regional user expectations. Across all geographies, regional operational resilience and responsiveness to regulatory changes remain paramount.

Insights into competitive behaviors, partnership models, and capability stacks that differentiate market leaders and fast followers in fertility testing devices

Competitive dynamics in the fertility testing device space are shaped by a combination of incumbents expanding digital capabilities, nimble challengers leveraging innovative form factors, and cross-sector entrants from wearables and digital health. Companies that excel at integrating clinical-grade sensing with frictionless user experiences tend to secure stronger partnerships with healthcare providers and telehealth platforms. Collaboration between device manufacturers and digital service providers is creating bundled offerings that combine hardware, software, and care coordination.

Strategic partnerships and licensing agreements are becoming more prevalent as firms seek to accelerate time to market without incurring the full cost of developing proprietary technologies. Many organizations are also investing in longitudinal data programs to demonstrate clinical utility and to support differentiated algorithmic insights. Meanwhile, companies with robust regulatory experience and global distribution networks enjoy advantages in scaling validated products across multiple jurisdictions. Competitive advantage increasingly relies on an ecosystem play that blends device reliability, data integrity, and pathway-to-care services.

Given the complexity of evidence requirements and commercialization pathways, alliances with academic centers, clinical trial networks, and specialty clinics are often used to generate credibility and accelerate clinician adoption. Firms that proactively build interoperable solutions and transparent algorithmic validation processes are best positioned to gain trust from both medical stakeholders and end users, thereby creating durable differentiation in a crowded and rapidly evolving landscape.

Actionable, prioritized strategic initiatives for manufacturers, distributors, and health systems to navigate risk and capture opportunities in fertility testing

Industry leaders should prioritize a set of strategic actions that preserve agility while building long-term competitive advantage. First, aligning product roadmaps with regulatory evidence requirements and privacy standards will reduce time to clinical acceptance and minimize rework. Second, investing in modular hardware platforms and software upgradeability will lower the cost of iterating on features and enable rapid response to user insights and regulatory changes. Third, diversifying supplier bases and considering regional manufacturing options will mitigate tariff exposure and shorten lead times.

Commercially, combining direct-to-consumer and clinical channel strategies can broaden reach while maintaining clinical credibility. Strategic partnerships with telehealth providers and specialty clinics can create referral pathways and support evidence generation. From a data perspective, transparent algorithmic validation, secure cloud practices, and clear user consent frameworks are essential to maintain trust and comply with evolving privacy regimes. Finally, building flexible pricing and subscription models tailored to different segments and geographies will enhance accessibility and create recurring revenue opportunities.

Execution of these priorities requires cross-functional governance that connects R&D, regulatory, commercial, and supply chain teams. By embedding scenario planning into strategic roadmaps and establishing rapid feedback loops from pilot markets, organizations can adapt to policy shifts and emerging user expectations while preserving product quality and clinical credibility.

Detailed mixed methods research approach combining expert interviews, evidence synthesis, and technical validation to produce defensible and operational insights

This research employs a mixed methods approach that blends primary qualitative interviews, structured secondary evidence synthesis, and technical validation to ensure robust and actionable conclusions. Primary inputs include interviews with clinicians, device engineers, regulatory specialists, and channel partners to capture practitioner perspectives, technical constraints, and real-world commercialization challenges. These stakeholder conversations are used to triangulate evidence and identify practical barriers to adoption across different segments and geographies.

Secondary evidence was synthesized from peer-reviewed literature, regulatory guidance documents, product specifications, and publicly available company disclosures to build a foundation of factual context. Technical validation exercises involved reviewing device specifications, algorithm documentation, and usability reports to assess claims around sensor performance and user experience. Where applicable, regulatory pathways and guidance were cross-checked with agency documentation to ensure recommendations align with current expectations.

Throughout the research process, rigorous quality controls were applied, including methodological peer review, consistency checks across data sources, and scenario-based sensitivity analysis to test the resilience of conclusions. The combination of stakeholder insights, documentary analysis, and technical review produces a defensible evidence base designed to support strategic decision making without relying on opaque assumptions.

A concise synthesis of strategic imperatives highlighting integration of technical excellence, evidence generation, and operational resilience for sustained success

The evolving fertility testing devices landscape presents both substantive opportunities and meaningful operational challenges. Technological advances unlock new value for consumers and clinicians, but realizing that potential requires deliberate alignment across product design, clinical validation, regulatory strategy, and supply chain resilience. Organizations that proactively address data integrity, privacy, and interoperability will be better positioned to translate device capabilities into integrated care pathways.

Strategic differentiation will come from combining reliable sensing with transparent analytics and service models that bridge home use and clinical contexts. Regional strategies must account for regulatory diversity and cultural nuances, while channel strategies should balance the scalability of online distribution with the credibility and reach of traditional retail and clinical channels. Finally, scenario planning for trade and tariff dynamics, coupled with supplier diversification, will be essential to protect timelines and margins.

In conclusion, success in this sector depends on an integrated approach that blends technical excellence with pragmatic commercialization and governance. Organizations that invest in evidence generation, forge credible clinical partnerships, and design products with modularity and privacy in mind will create durable competitive advantage in a rapidly changing ecosystem.

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Definition
  • 1.3. Market Segmentation & Coverage
  • 1.4. Years Considered for the Study
  • 1.5. Currency Considered for the Study
  • 1.6. Language Considered for the Study
  • 1.7. Key Stakeholders

2. Research Methodology

  • 2.1. Introduction
  • 2.2. Research Design
    • 2.2.1. Primary Research
    • 2.2.2. Secondary Research
  • 2.3. Research Framework
    • 2.3.1. Qualitative Analysis
    • 2.3.2. Quantitative Analysis
  • 2.4. Market Size Estimation
    • 2.4.1. Top-Down Approach
    • 2.4.2. Bottom-Up Approach
  • 2.5. Data Triangulation
  • 2.6. Research Outcomes
  • 2.7. Research Assumptions
  • 2.8. Research Limitations

3. Executive Summary

  • 3.1. Introduction
  • 3.2. CXO Perspective
  • 3.3. Market Size & Growth Trends
  • 3.4. Market Share Analysis, 2025
  • 3.5. FPNV Positioning Matrix, 2025
  • 3.6. New Revenue Opportunities
  • 3.7. Next-Generation Business Models
  • 3.8. Industry Roadmap

4. Market Overview

  • 4.1. Introduction
  • 4.2. Industry Ecosystem & Value Chain Analysis
    • 4.2.1. Supply-Side Analysis
    • 4.2.2. Demand-Side Analysis
    • 4.2.3. Stakeholder Analysis
  • 4.3. Porter's Five Forces Analysis
  • 4.4. PESTLE Analysis
  • 4.5. Market Outlook
    • 4.5.1. Near-Term Market Outlook (0-2 Years)
    • 4.5.2. Medium-Term Market Outlook (3-5 Years)
    • 4.5.3. Long-Term Market Outlook (5-10 Years)
  • 4.6. Go-to-Market Strategy

5. Market Insights

  • 5.1. Consumer Insights & End-User Perspective
  • 5.2. Consumer Experience Benchmarking
  • 5.3. Opportunity Mapping
  • 5.4. Distribution Channel Analysis
  • 5.5. Pricing Trend Analysis
  • 5.6. Regulatory Compliance & Standards Framework
  • 5.7. ESG & Sustainability Analysis
  • 5.8. Disruption & Risk Scenarios
  • 5.9. Return on Investment & Cost-Benefit Analysis

6. Cumulative Impact of United States Tariffs 2025

7. Cumulative Impact of Artificial Intelligence 2025

8. Fertility Testing Devices Market, by Product Type

  • 8.1. Fertility Monitors
    • 8.1.1. Handheld Monitors
    • 8.1.2. Wrist Monitors
  • 8.2. Ovulation Test Kits
    • 8.2.1. Digital
    • 8.2.2. Traditional
  • 8.3. Pregnancy Test Kits
    • 8.3.1. Digital
    • 8.3.2. Traditional

9. Fertility Testing Devices Market, by Technology

  • 9.1. Digital
  • 9.2. Traditional

10. Fertility Testing Devices Market, by End User

  • 10.1. Clinical Use
  • 10.2. Home Use

11. Fertility Testing Devices Market, by Sales Channel

  • 11.1. Online
  • 11.2. Offline

12. Fertility Testing Devices Market, by Region

  • 12.1. Americas
    • 12.1.1. North America
    • 12.1.2. Latin America
  • 12.2. Europe, Middle East & Africa
    • 12.2.1. Europe
    • 12.2.2. Middle East
    • 12.2.3. Africa
  • 12.3. Asia-Pacific

13. Fertility Testing Devices Market, by Group

  • 13.1. ASEAN
  • 13.2. GCC
  • 13.3. European Union
  • 13.4. BRICS
  • 13.5. G7
  • 13.6. NATO

14. Fertility Testing Devices Market, by Country

  • 14.1. United States
  • 14.2. Canada
  • 14.3. Mexico
  • 14.4. Brazil
  • 14.5. United Kingdom
  • 14.6. Germany
  • 14.7. France
  • 14.8. Russia
  • 14.9. Italy
  • 14.10. Spain
  • 14.11. China
  • 14.12. India
  • 14.13. Japan
  • 14.14. Australia
  • 14.15. South Korea

15. United States Fertility Testing Devices Market

16. China Fertility Testing Devices Market

17. Competitive Landscape

  • 17.1. Market Concentration Analysis, 2025
    • 17.1.1. Concentration Ratio (CR)
    • 17.1.2. Herfindahl Hirschman Index (HHI)
  • 17.2. Recent Developments & Impact Analysis, 2025
  • 17.3. Product Portfolio Analysis, 2025
  • 17.4. Benchmarking Analysis, 2025
  • 17.5. Abbott Laboratories Inc.
  • 17.6. Advait Labs Private Limited.
  • 17.7. Babystart Inc.
  • 17.8. bioMerieux SA
  • 17.9. Church & Dwight Co., Inc.
  • 17.10. Clearblue
  • 17.11. Easy Healthcare Corporation
  • 17.12. First Response
  • 17.13. Geratherm Medical AG
  • 17.14. Hi-Precision Company
  • 17.15. Medical Electronic Systems LLC
  • 17.16. NFI Consumer Healthcare
  • 17.17. Piramal Enterprises Ltd
  • 17.18. Precision Biosensor Inc.
  • 17.19. QuidelOrtho Corporation
  • 17.20. Rite Aid Corporation
  • 17.21. Rohto Pharmaceutical Co., Ltd.
  • 17.22. Swiss Precision Diagnostics GmbH
  • 17.23. Tempdrop Ltd
  • 17.24. UE Lifecycles Inc.

LIST OF FIGURES

  • FIGURE 1. GLOBAL FERTILITY TESTING DEVICES MARKET SIZE, 2018-2032 (USD MILLION)
  • FIGURE 2. GLOBAL FERTILITY TESTING DEVICES MARKET SHARE, BY KEY PLAYER, 2025
  • FIGURE 3. GLOBAL FERTILITY TESTING DEVICES MARKET, FPNV POSITIONING MATRIX, 2025
  • FIGURE 4. GLOBAL FERTILITY TESTING DEVICES MARKET SIZE, BY PRODUCT TYPE, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 5. GLOBAL FERTILITY TESTING DEVICES MARKET SIZE, BY TECHNOLOGY, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 6. GLOBAL FERTILITY TESTING DEVICES MARKET SIZE, BY END USER, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 7. GLOBAL FERTILITY TESTING DEVICES MARKET SIZE, BY SALES CHANNEL, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 8. GLOBAL FERTILITY TESTING DEVICES MARKET SIZE, BY REGION, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 9. GLOBAL FERTILITY TESTING DEVICES MARKET SIZE, BY GROUP, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 10. GLOBAL FERTILITY TESTING DEVICES MARKET SIZE, BY COUNTRY, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 11. UNITED STATES FERTILITY TESTING DEVICES MARKET SIZE, 2018-2032 (USD MILLION)
  • FIGURE 12. CHINA FERTILITY TESTING DEVICES MARKET SIZE, 2018-2032 (USD MILLION)

LIST OF TABLES

  • TABLE 1. GLOBAL FERTILITY TESTING DEVICES MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 2. GLOBAL FERTILITY TESTING DEVICES MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 3. GLOBAL FERTILITY TESTING DEVICES MARKET SIZE, BY FERTILITY MONITORS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 4. GLOBAL FERTILITY TESTING DEVICES MARKET SIZE, BY FERTILITY MONITORS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 5. GLOBAL FERTILITY TESTING DEVICES MARKET SIZE, BY FERTILITY MONITORS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 6. GLOBAL FERTILITY TESTING DEVICES MARKET SIZE, BY FERTILITY MONITORS, 2018-2032 (USD MILLION)
  • TABLE 7. GLOBAL FERTILITY TESTING DEVICES MARKET SIZE, BY HANDHELD MONITORS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 8. GLOBAL FERTILITY TESTING DEVICES MARKET SIZE, BY HANDHELD MONITORS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 9. GLOBAL FERTILITY TESTING DEVICES MARKET SIZE, BY HANDHELD MONITORS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 10. GLOBAL FERTILITY TESTING DEVICES MARKET SIZE, BY WRIST MONITORS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 11. GLOBAL FERTILITY TESTING DEVICES MARKET SIZE, BY WRIST MONITORS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 12. GLOBAL FERTILITY TESTING DEVICES MARKET SIZE, BY WRIST MONITORS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 13. GLOBAL FERTILITY TESTING DEVICES MARKET SIZE, BY OVULATION TEST KITS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 14. GLOBAL FERTILITY TESTING DEVICES MARKET SIZE, BY OVULATION TEST KITS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 15. GLOBAL FERTILITY TESTING DEVICES MARKET SIZE, BY OVULATION TEST KITS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 16. GLOBAL FERTILITY TESTING DEVICES MARKET SIZE, BY OVULATION TEST KITS, 2018-2032 (USD MILLION)
  • TABLE 17. GLOBAL FERTILITY TESTING DEVICES MARKET SIZE, BY DIGITAL, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 18. GLOBAL FERTILITY TESTING DEVICES MARKET SIZE, BY DIGITAL, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 19. GLOBAL FERTILITY TESTING DEVICES MARKET SIZE, BY DIGITAL, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 20. GLOBAL FERTILITY TESTING DEVICES MARKET SIZE, BY TRADITIONAL, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 21. GLOBAL FERTILITY TESTING DEVICES MARKET SIZE, BY TRADITIONAL, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 22. GLOBAL FERTILITY TESTING DEVICES MARKET SIZE, BY TRADITIONAL, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 23. GLOBAL FERTILITY TESTING DEVICES MARKET SIZE, BY PREGNANCY TEST KITS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 24. GLOBAL FERTILITY TESTING DEVICES MARKET SIZE, BY PREGNANCY TEST KITS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 25. GLOBAL FERTILITY TESTING DEVICES MARKET SIZE, BY PREGNANCY TEST KITS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 26. GLOBAL FERTILITY TESTING DEVICES MARKET SIZE, BY PREGNANCY TEST KITS, 2018-2032 (USD MILLION)
  • TABLE 27. GLOBAL FERTILITY TESTING DEVICES MARKET SIZE, BY DIGITAL, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 28. GLOBAL FERTILITY TESTING DEVICES MARKET SIZE, BY DIGITAL, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 29. GLOBAL FERTILITY TESTING DEVICES MARKET SIZE, BY DIGITAL, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 30. GLOBAL FERTILITY TESTING DEVICES MARKET SIZE, BY TRADITIONAL, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 31. GLOBAL FERTILITY TESTING DEVICES MARKET SIZE, BY TRADITIONAL, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 32. GLOBAL FERTILITY TESTING DEVICES MARKET SIZE, BY TRADITIONAL, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 33. GLOBAL FERTILITY TESTING DEVICES MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 34. GLOBAL FERTILITY TESTING DEVICES MARKET SIZE, BY DIGITAL, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 35. GLOBAL FERTILITY TESTING DEVICES MARKET SIZE, BY DIGITAL, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 36. GLOBAL FERTILITY TESTING DEVICES MARKET SIZE, BY DIGITAL, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 37. GLOBAL FERTILITY TESTING DEVICES MARKET SIZE, BY TRADITIONAL, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 38. GLOBAL FERTILITY TESTING DEVICES MARKET SIZE, BY TRADITIONAL, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 39. GLOBAL FERTILITY TESTING DEVICES MARKET SIZE, BY TRADITIONAL, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 40. GLOBAL FERTILITY TESTING DEVICES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 41. GLOBAL FERTILITY TESTING DEVICES MARKET SIZE, BY CLINICAL USE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 42. GLOBAL FERTILITY TESTING DEVICES MARKET SIZE, BY CLINICAL USE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 43. GLOBAL FERTILITY TESTING DEVICES MARKET SIZE, BY CLINICAL USE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 44. GLOBAL FERTILITY TESTING DEVICES MARKET SIZE, BY HOME USE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 45. GLOBAL FERTILITY TESTING DEVICES MARKET SIZE, BY HOME USE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 46. GLOBAL FERTILITY TESTING DEVICES MARKET SIZE, BY HOME USE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 47. GLOBAL FERTILITY TESTING DEVICES MARKET SIZE, BY SALES CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 48. GLOBAL FERTILITY TESTING DEVICES MARKET SIZE, BY ONLINE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 49. GLOBAL FERTILITY TESTING DEVICES MARKET SIZE, BY ONLINE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 50. GLOBAL FERTILITY TESTING DEVICES MARKET SIZE, BY ONLINE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 51. GLOBAL FERTILITY TESTING DEVICES MARKET SIZE, BY OFFLINE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 52. GLOBAL FERTILITY TESTING DEVICES MARKET SIZE, BY OFFLINE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 53. GLOBAL FERTILITY TESTING DEVICES MARKET SIZE, BY OFFLINE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 54. GLOBAL FERTILITY TESTING DEVICES MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 55. AMERICAS FERTILITY TESTING DEVICES MARKET SIZE, BY SUBREGION, 2018-2032 (USD MILLION)
  • TABLE 56. AMERICAS FERTILITY TESTING DEVICES MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 57. AMERICAS FERTILITY TESTING DEVICES MARKET SIZE, BY FERTILITY MONITORS, 2018-2032 (USD MILLION)
  • TABLE 58. AMERICAS FERTILITY TESTING DEVICES MARKET SIZE, BY OVULATION TEST KITS, 2018-2032 (USD MILLION)
  • TABLE 59. AMERICAS FERTILITY TESTING DEVICES MARKET SIZE, BY PREGNANCY TEST KITS, 2018-2032 (USD MILLION)
  • TABLE 60. AMERICAS FERTILITY TESTING DEVICES MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 61. AMERICAS FERTILITY TESTING DEVICES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 62. AMERICAS FERTILITY TESTING DEVICES MARKET SIZE, BY SALES CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 63. NORTH AMERICA FERTILITY TESTING DEVICES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 64. NORTH AMERICA FERTILITY TESTING DEVICES MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 65. NORTH AMERICA FERTILITY TESTING DEVICES MARKET SIZE, BY FERTILITY MONITORS, 2018-2032 (USD MILLION)
  • TABLE 66. NORTH AMERICA FERTILITY TESTING DEVICES MARKET SIZE, BY OVULATION TEST KITS, 2018-2032 (USD MILLION)
  • TABLE 67. NORTH AMERICA FERTILITY TESTING DEVICES MARKET SIZE, BY PREGNANCY TEST KITS, 2018-2032 (USD MILLION)
  • TABLE 68. NORTH AMERICA FERTILITY TESTING DEVICES MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 69. NORTH AMERICA FERTILITY TESTING DEVICES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 70. NORTH AMERICA FERTILITY TESTING DEVICES MARKET SIZE, BY SALES CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 71. LATIN AMERICA FERTILITY TESTING DEVICES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 72. LATIN AMERICA FERTILITY TESTING DEVICES MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 73. LATIN AMERICA FERTILITY TESTING DEVICES MARKET SIZE, BY FERTILITY MONITORS, 2018-2032 (USD MILLION)
  • TABLE 74. LATIN AMERICA FERTILITY TESTING DEVICES MARKET SIZE, BY OVULATION TEST KITS, 2018-2032 (USD MILLION)
  • TABLE 75. LATIN AMERICA FERTILITY TESTING DEVICES MARKET SIZE, BY PREGNANCY TEST KITS, 2018-2032 (USD MILLION)
  • TABLE 76. LATIN AMERICA FERTILITY TESTING DEVICES MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 77. LATIN AMERICA FERTILITY TESTING DEVICES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 78. LATIN AMERICA FERTILITY TESTING DEVICES MARKET SIZE, BY SALES CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 79. EUROPE, MIDDLE EAST & AFRICA FERTILITY TESTING DEVICES MARKET SIZE, BY SUBREGION, 2018-2032 (USD MILLION)
  • TABLE 80. EUROPE, MIDDLE EAST & AFRICA FERTILITY TESTING DEVICES MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 81. EUROPE, MIDDLE EAST & AFRICA FERTILITY TESTING DEVICES MARKET SIZE, BY FERTILITY MONITORS, 2018-2032 (USD MILLION)
  • TABLE 82. EUROPE, MIDDLE EAST & AFRICA FERTILITY TESTING DEVICES MARKET SIZE, BY OVULATION TEST KITS, 2018-2032 (USD MILLION)
  • TABLE 83. EUROPE, MIDDLE EAST & AFRICA FERTILITY TESTING DEVICES MARKET SIZE, BY PREGNANCY TEST KITS, 2018-2032 (USD MILLION)
  • TABLE 84. EUROPE, MIDDLE EAST & AFRICA FERTILITY TESTING DEVICES MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 85. EUROPE, MIDDLE EAST & AFRICA FERTILITY TESTING DEVICES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 86. EUROPE, MIDDLE EAST & AFRICA FERTILITY TESTING DEVICES MARKET SIZE, BY SALES CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 87. EUROPE FERTILITY TESTING DEVICES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 88. EUROPE FERTILITY TESTING DEVICES MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 89. EUROPE FERTILITY TESTING DEVICES MARKET SIZE, BY FERTILITY MONITORS, 2018-2032 (USD MILLION)
  • TABLE 90. EUROPE FERTILITY TESTING DEVICES MARKET SIZE, BY OVULATION TEST KITS, 2018-2032 (USD MILLION)
  • TABLE 91. EUROPE FERTILITY TESTING DEVICES MARKET SIZE, BY PREGNANCY TEST KITS, 2018-2032 (USD MILLION)
  • TABLE 92. EUROPE FERTILITY TESTING DEVICES MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 93. EUROPE FERTILITY TESTING DEVICES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 94. EUROPE FERTILITY TESTING DEVICES MARKET SIZE, BY SALES CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 95. MIDDLE EAST FERTILITY TESTING DEVICES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 96. MIDDLE EAST FERTILITY TESTING DEVICES MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 97. MIDDLE EAST FERTILITY TESTING DEVICES MARKET SIZE, BY FERTILITY MONITORS, 2018-2032 (USD MILLION)
  • TABLE 98. MIDDLE EAST FERTILITY TESTING DEVICES MARKET SIZE, BY OVULATION TEST KITS, 2018-2032 (USD MILLION)
  • TABLE 99. MIDDLE EAST FERTILITY TESTING DEVICES MARKET SIZE, BY PREGNANCY TEST KITS, 2018-2032 (USD MILLION)
  • TABLE 100. MIDDLE EAST FERTILITY TESTING DEVICES MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 101. MIDDLE EAST FERTILITY TESTING DEVICES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 102. MIDDLE EAST FERTILITY TESTING DEVICES MARKET SIZE, BY SALES CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 103. AFRICA FERTILITY TESTING DEVICES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 104. AFRICA FERTILITY TESTING DEVICES MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 105. AFRICA FERTILITY TESTING DEVICES MARKET SIZE, BY FERTILITY MONITORS, 2018-2032 (USD MILLION)
  • TABLE 106. AFRICA FERTILITY TESTING DEVICES MARKET SIZE, BY OVULATION TEST KITS, 2018-2032 (USD MILLION)
  • TABLE 107. AFRICA FERTILITY TESTING DEVICES MARKET SIZE, BY PREGNANCY TEST KITS, 2018-2032 (USD MILLION)
  • TABLE 108. AFRICA FERTILITY TESTING DEVICES MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 109. AFRICA FERTILITY TESTING DEVICES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 110. AFRICA FERTILITY TESTING DEVICES MARKET SIZE, BY SALES CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 111. ASIA-PACIFIC FERTILITY TESTING DEVICES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 112. ASIA-PACIFIC FERTILITY TESTING DEVICES MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 113. ASIA-PACIFIC FERTILITY TESTING DEVICES MARKET SIZE, BY FERTILITY MONITORS, 2018-2032 (USD MILLION)
  • TABLE 114. ASIA-PACIFIC FERTILITY TESTING DEVICES MARKET SIZE, BY OVULATION TEST KITS, 2018-2032 (USD MILLION)
  • TABLE 115. ASIA-PACIFIC FERTILITY TESTING DEVICES MARKET SIZE, BY PREGNANCY TEST KITS, 2018-2032 (USD MILLION)
  • TABLE 116. ASIA-PACIFIC FERTILITY TESTING DEVICES MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 117. ASIA-PACIFIC FERTILITY TESTING DEVICES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 118. ASIA-PACIFIC FERTILITY TESTING DEVICES MARKET SIZE, BY SALES CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 119. GLOBAL FERTILITY TESTING DEVICES MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 120. ASEAN FERTILITY TESTING DEVICES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 121. ASEAN FERTILITY TESTING DEVICES MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 122. ASEAN FERTILITY TESTING DEVICES MARKET SIZE, BY FERTILITY MONITORS, 2018-2032 (USD MILLION)
  • TABLE 123. ASEAN FERTILITY TESTING DEVICES MARKET SIZE, BY OVULATION TEST KITS, 2018-2032 (USD MILLION)
  • TABLE 124. ASEAN FERTILITY TESTING DEVICES MARKET SIZE, BY PREGNANCY TEST KITS, 2018-2032 (USD MILLION)
  • TABLE 125. ASEAN FERTILITY TESTING DEVICES MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 126. ASEAN FERTILITY TESTING DEVICES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 127. ASEAN FERTILITY TESTING DEVICES MARKET SIZE, BY SALES CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 128. GCC FERTILITY TESTING DEVICES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 129. GCC FERTILITY TESTING DEVICES MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 130. GCC FERTILITY TESTING DEVICES MARKET SIZE, BY FERTILITY MONITORS, 2018-2032 (USD MILLION)
  • TABLE 131. GCC FERTILITY TESTING DEVICES MARKET SIZE, BY OVULATION TEST KITS, 2018-2032 (USD MILLION)
  • TABLE 132. GCC FERTILITY TESTING DEVICES MARKET SIZE, BY PREGNANCY TEST KITS, 2018-2032 (USD MILLION)
  • TABLE 133. GCC FERTILITY TESTING DEVICES MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 134. GCC FERTILITY TESTING DEVICES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 135. GCC FERTILITY TESTING DEVICES MARKET SIZE, BY SALES CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 136. EUROPEAN UNION FERTILITY TESTING DEVICES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 137. EUROPEAN UNION FERTILITY TESTING DEVICES MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 138. EUROPEAN UNION FERTILITY TESTING DEVICES MARKET SIZE, BY FERTILITY MONITORS, 2018-2032 (USD MILLION)
  • TABLE 139. EUROPEAN UNION FERTILITY TESTING DEVICES MARKET SIZE, BY OVULATION TEST KITS, 2018-2032 (USD MILLION)
  • TABLE 140. EUROPEAN UNION FERTILITY TESTING DEVICES MARKET SIZE, BY PREGNANCY TEST KITS, 2018-2032 (USD MILLION)
  • TABLE 141. EUROPEAN UNION FERTILITY TESTING DEVICES MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 142. EUROPEAN UNION FERTILITY TESTING DEVICES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 143. EUROPEAN UNION FERTILITY TESTING DEVICES MARKET SIZE, BY SALES CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 144. BRICS FERTILITY TESTING DEVICES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 145. BRICS FERTILITY TESTING DEVICES MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 146. BRICS FERTILITY TESTING DEVICES MARKET SIZE, BY FERTILITY MONITORS, 2018-2032 (USD MILLION)
  • TABLE 147. BRICS FERTILITY TESTING DEVICES MARKET SIZE, BY OVULATION TEST KITS, 2018-2032 (USD MILLION)
  • TABLE 148. BRICS FERTILITY TESTING DEVICES MARKET SIZE, BY PREGNANCY TEST KITS, 2018-2032 (USD MILLION)
  • TABLE 149. BRICS FERTILITY TESTING DEVICES MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 150. BRICS FERTILITY TESTING DEVICES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 151. BRICS FERTILITY TESTING DEVICES MARKET SIZE, BY SALES CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 152. G7 FERTILITY TESTING DEVICES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 153. G7 FERTILITY TESTING DEVICES MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 154. G7 FERTILITY TESTING DEVICES MARKET SIZE, BY FERTILITY MONITORS, 2018-2032 (USD MILLION)
  • TABLE 155. G7 FERTILITY TESTING DEVICES MARKET SIZE, BY OVULATION TEST KITS, 2018-2032 (USD MILLION)
  • TABLE 156. G7 FERTILITY TESTING DEVICES MARKET SIZE, BY PREGNANCY TEST KITS, 2018-2032 (USD MILLION)
  • TABLE 157. G7 FERTILITY TESTING DEVICES MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 158. G7 FERTILITY TESTING DEVICES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 159. G7 FERTILITY TESTING DEVICES MARKET SIZE, BY SALES CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 160. NATO FERTILITY TESTING DEVICES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 161. NATO FERTILITY TESTING DEVICES MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 162. NATO FERTILITY TESTING DEVICES MARKET SIZE, BY FERTILITY MONITORS, 2018-2032 (USD MILLION)
  • TABLE 163. NATO FERTILITY TESTING DEVICES MARKET SIZE, BY OVULATION TEST KITS, 2018-2032 (USD MILLION)
  • TABLE 164. NATO FERTILITY TESTING DEVICES MARKET SIZE, BY PREGNANCY TEST KITS, 2018-2032 (USD MILLION)
  • TABLE 165. NATO FERTILITY TESTING DEVICES MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 166. NATO FERTILITY TESTING DEVICES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 167. NATO FERTILITY TESTING DEVICES MARKET SIZE, BY SALES CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 168. GLOBAL FERTILITY TESTING DEVICES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 169. UNITED STATES FERTILITY TESTING DEVICES MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 170. UNITED STATES FERTILITY TESTING DEVICES MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 171. UNITED STATES FERTILITY TESTING DEVICES MARKET SIZE, BY FERTILITY MONITORS, 2018-2032 (USD MILLION)
  • TABLE 172. UNITED STATES FERTILITY TESTING DEVICES MARKET SIZE, BY OVULATION TEST KITS, 2018-2032 (USD MILLION)
  • TABLE 173. UNITED STATES FERTILITY TESTING DEVICES MARKET SIZE, BY PREGNANCY TEST KITS, 2018-2032 (USD MILLION)
  • TABLE 174. UNITED STATES FERTILITY TESTING DEVICES MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 175. UNITED STATES FERTILITY TESTING DEVICES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 176. UNITED STATES FERTILITY TESTING DEVICES MARKET SIZE, BY SALES CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 177. CHINA FERTILITY TESTING DEVICES MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 178. CHINA FERTILITY TESTING DEVICES MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 179. CHINA FERTILITY TESTING DEVICES MARKET SIZE, BY FERTILITY MONITORS, 2018-2032 (USD MILLION)
  • TABLE 180. CHINA FERTILITY TESTING DEVICES MARKET SIZE, BY OVULATION TEST KITS, 2018-2032 (USD MILLION)
  • TABLE 181. CHINA FERTILITY TESTING DEVICES MARKET SIZE, BY PREGNANCY TEST KITS, 2018-2032 (USD MILLION)
  • TABLE 182. CHINA FERTILITY TESTING DEVICES MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 183. CHINA FERTILITY TESTING DEVICES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 184. CHINA FERTILITY TESTING DEVICES MARKET SIZE, BY SALES CHANNEL, 2018-2032 (USD MILLION)